Schedule 13G ownership disclosure
Spark Therapeutics, Inc.
Security class unavailable · CUSIP: 84652J103
Event date: 2019-04-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 2.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001567619-19-009848
- Form type
- SC 13G
- Filer
- JPMORGAN CHASE & CO
- CIK
- CIK 19617
- Filed
- May 06, 2019
- Reporting period
- Apr 30, 2019
- Description
- Schedule 13G beneficial ownership